We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$53.5M
1-Year Est. Return
80.67%
This Fund
S&P 500
This Quarter
Est. Return
-19.92%
1 Year Est. Return
+80.67%
3 Year Est. Return
+80.2%
5 Year Est. Return
+49.87%
10 Year Est. Return
+446.13%
AUM
$788M
AUM Growth
-$156M
(-16%)
Cap. Flow
-$1.03B
Cap. Flow
% of AUM
-130.35%
Top 10 Holdings %
Top 10 Hldgs %
80.89%
Holding
183
New
45
Increased
18
Reduced
27
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$6.91M |
| 2 |
Vale
VALE
|
+$5.95M |
| 3 |
W.R. Berkley
WRB
|
+$5.25M |
| 4 |
Equitable Holdings
EQH
|
+$4.37M |
| 5 |
Lam Research
LRCX
|
+$4.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Denali Therapeutics
DNLI
|
+$634M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$40.6M |
| 3 |
UnitedHealth
UNH
|
+$35.1M |
| 4 |
Qualcomm
QCOM
|
+$35.1M |
| 5 |
Amazon
AMZN
|
+$34.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 72.44% |
| 2 | Financials | 6.88% |
| 3 | Miscellaneous | 6.06% |
| 4 | Technology | 5.83% |
| 5 | Materials | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Denali Therapeutics
DNLI
$3.27B
| $570M | 72.4% |
9,984,836
-9,477,664
| -49% | -$634M |
|
|
2
Alphabet (Google) Class A
GOOGL
$4.21T
| $7.84M | 1% |
76,000
+70,000
| +1,167% | +$6.91M |
|
|
3
W.R. Berkley
WRB
$26.2B
| $7.81M | 0.99% |
233,296
+170,168
| +270% | +$5.25M |
|
4
Micron Technology
MU
$1.05T
| $7.77M | 0.99% |
88,053
-10,445
| -11% | -$886K |
|
|
5
Vale
VALE
$61.6B
| $5.93M | 0.75% |
+341,000
| New | +$5.95M |
|
6
UDR
UDR
$11.3B
| $5.92M | 0.75% |
135,000
+71,056
| +111% | +$2.94M |
|
7
ArcelorMittal
MT
$55B
| $5.72M | 0.73% |
196,000
+43,592
| +29% | +$1.07M |
|
|
8
Equitable Holdings
EQH
$14.6B
| $4.95M | 0.63% |
+151,636
| New | +$4.37M |
|
9
Lincoln National
LNC
$8.3B
| $4.81M | 0.61% |
77,307
+55,971
| +262% | +$3.09M |
|
10
Hartford Financial Services
HIG
$36.9B
| $4.72M | 0.6% |
70,651
-22,541
| -24% | -$1.22M |
|
11
Silicon Motion
SIMO
$7.96B
| $4.63M | 0.59% |
78,044
-25,024
| -24% | -$1.42M |
|
|
12
Lam Research
LRCX
$336B
| $4.46M | 0.57% |
+75,000
| New | +$4.09M |
|
13
Lumentum
LITE
$75.8B
| $4.32M | 0.55% |
47,248
+18,000
| +62% | +$1.67M |
|
14
Western Digital
WDC
$151B
| $4.27M | 0.54% |
+84,672
| New | +$3.96M |
|
15
Alcoa
AA
$12.2B
| $4.08M | 0.52% |
+125,500
| New | +$3.18M |
|
16
Microchip Technology
MCHP
$38.7B
| $3.88M | 0.49% |
50,000
+22,700
| +83% | +$1.69M |
|
17
Arthur J. Gallagher & Co
AJG
$64.6B
| $3.77M | 0.48% |
+30,259
| New | +$3.65M |
|
|
UFS
18
DELISTED
DOMTAR CORPORATION (New)
UFS
| $3.71M | 0.47% |
+100,506
| New | +$3.47M |
|
19
Wheaton Precious Metals
WPM
$67.1B
| $3.58M | 0.46% |
93,800
-17,000
| -15% | -$675K |
|
20
Ternium
TX
$11B
| $3.55M | 0.45% |
91,484
| – | – |
|
21
Brighthouse Financial
BHF
$2.81B
| $3.51M | 0.45% |
+79,313
| New | +$3.26M |
|
22
American Financial Group
AFG
$11.9B
| $3.45M | 0.44% |
+30,216
| New | +$3.12M |
|
23
Assurant
AIZ
$13.9B
| $3.45M | 0.44% |
24,306
-2,647
| -10% | -$357K |
|
24
Voya Financial
VOYA
$9.22B
| $2.9M | 0.37% |
45,485
-36,384
| -44% | -$2.19M |
|
25
Applied Materials
AMAT
$333B
| $2.83M | 0.36% |
21,156
-65,000
| -75% | -$7.17M |
|
Similar funds
OM
ICCON
HCM
ETCM
IDBONY
PCM
TCDRS
FPAM
Crestline Management's Q1 2021 Portfolio in Review
As of Q1 2021, Crestline Management held 183 positions worth $788M, down 16% from $943M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Crestline Management withdrew a net $1.03B in Q1 2021, closing 85 positions and reducing 27 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $40.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 41% a quarter earlier, followed by Financials and Miscellaneous.
Against the trend, Crestline Management opened a new position in Vale worth $5.93M.
- Crestline Management's largest Q1 2021 buy was Vale: 341,000 shares worth $5.93M.
- Crestline Management added most to Alphabet (Google) Class A in Q1 2021, an estimated $6.91M increase.
- Crestline Management's biggest Q1 2021 reduction was Denali Therapeutics, cutting an estimated $634M.
- Crestline Management fully exited Berkshire Hathaway Class B in Q1 2021, selling an estimated $40.6M.
- Crestline Management's ten largest holdings make up 81% of its $788M portfolio in Q1 2021.
- Crestline Management opened 45 new positions and closed 85 in Q1 2021.
- Crestline Management's portfolio value fell 16% quarter-over-quarter to $788M.
Based on Crestline Management's 13F filing for Q1 2021, filed 14 May 2021.